close
read more
Our company
Governance
Global presence
Key figures
Story
Vocation, vision and values
Culture
Financial Results
Servier Institute
Our healthcare offering
Servier medicines
Generic medicines
e-Health solutions
Our areas of expertise
Research & Development
Therapeutic areas
Development portfolio
Clinical trials
Regulatory affairs
Pharmacovigilance
Servier Paris-Saclay R&D Institute
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Third-Party Sponsor studies
Business development & licensing
Our commitments
Patient
Ethics
Compliance policy
CSR approach
Fight against counterfeiting
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate publishing
Medical publishing
FR
MEDIATOR INFORMATION
NEWS
ROOM
News
Press release
Insight
Corporate publishing
Medical publishing
Servier certified Top Employer Europe!
25 / 01 / 2021
News
The 2019/2020 annual report is out!
22 / 01 / 2021
News
Neurological diseases: Servier partners with MiNA Therapeutics
21 / 01 / 2021
News
Servier presents its 2019/20 annual results, its R&D strategy and pipeline
19 / 01 / 2021
News
Servier: THE place to work!
15 / 01 / 2021
News
L’Institut Servier: “emergency sponsor” of the Neurocovid program
08 / 01 / 2021
News
Pascal Lemaire appointed Executive Vice President Finance
07 / 01 / 2021
News
Neurological Diseases: Servier and X-Chem Sign Partnership Agreement
06 / 01 / 2021
News
SERVIER LOCAL SHARED VALUE: FOR A POSITIVE FOOTPRINT!
22 / 12 / 2020
News
Servier to Acquire Agios Pharmaceuticals’ Oncology Business
21 / 12 / 2020
News
Colorectal Cancer: Servier and Celsius Therapeutics collaborate for Target Discovery
21 / 12 / 2020
News
Servier opens its Artificial Intelligence Hub in Montreal
14 / 12 / 2020
News